| NOBEL Pharma Schweiz AG - Atorvastatin NOBEL 40 mg, Filmtabletten | | 69098 | | 03 | | Atorvastatin NOBEL 40 mg | | Filmtabletten | | C10AA05 | | Atorvastatin | | 06.06.2024 | | |
| | Composition | | atorvastatinum 40 mg ut atorvastatinum calcicum trihydricum, calcii carbonas, lactosum monohydricum 128.3 mg, cellulosum microcristallinum, carmellosum natricum conexum, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, lecithinum, xanthani gummi, pro compresso obducto corresp. natrium max. 4.5 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Atorvastatine | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Calcium Carbonate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Lactose Monohydrate | 128.3 mg | | | Lecithine | | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Talcum | | | | Xanthani Gummi | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 30 | DDP | DDP | B | | Non | | 006 | 100 | DDP | DDP | B | | Non |
|
|
